{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:43:25Z","timestamp":1791938605698,"version":"4.3.4"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:p>Objective. A wide variability in the incidence of severe retinopathy of prematurity (ROP) is reported by different centers. The altered regulation of vascular endothelial growth factor from repeated episodes of hyperoxia and hypoxia is 1 important factor in the pathogenesis of ROP. Strict management of O2 delivery and monitoring to minimize these episodes may be associated with decreased rates of ROP. The objective of this study was to compare the incidence of and need for surgery for severe ROP (stages \u22653) in infants of 500 to 1500 g birth weight before and after the implementation of a new clinical practice of O2 management in a large level 3 neonatal intensive care unit (NICU).<\/jats:p><jats:p>Methods. An oxygen management policy that included strict guidelines in the practices of increasing and weaning of fraction of inspired oxygen (Fio2) and the monitoring of O2 saturation parameters in the delivery room, during in-house transport of infants to the NICU, and throughout hospitalization was implemented in April 1998. The main objectives were to monitor oxygenation levels more precisely and to avoid hyperoxia and repeated episodes of hypoxia-hyperoxia in very low birth weight infants. Included in the policy were equipment for monitoring, initiation of monitoring at birth, avoidance of repeated increases and decreases of the Fio2, minimization of \u201ctitration\u201d of Fio2, modification of previously used alarm limits, and others. After an educational process, each staff member signed an agreement stating understanding of and future compliance with the guidelines. Examinations were performed by experienced ophthalmologists following international classification and American Academy of Pediatrics recommendations. ROP data from January 1997 to December 2002 for infants of 500 to 1500 g were analyzed as usual and also have been reported to Vermont Oxford Network since 1998.<\/jats:p><jats:p>Results. The incidence of ROP 3 to 4 at this center decreased consistently in a 5-year period from 12.5% in 1997 to 2.5% in 2001. The need for ROP laser treatment decreased from 4.5% in 1997 to 0% in the last 3 years.<\/jats:p><jats:p>Conclusion. We observed a significant decrease in the rate of severe ROP in very low birth weight infants in association with an educational program provided to all NICU staff and the implementation and enforcement of clinical practices of O2 management and monitoring. Although several confounders cannot be excluded, it is likely that differences in these clinical practices may be, at least in part, responsible for the documented intercenter variability in rates of ROP.<\/jats:p>","DOI":"10.1542\/peds.111.2.339","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"339-345","source":"Crossref","is-referenced-by-count":374,"title":["Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants?"],"prefix":"10.1542","volume":"111","author":[{"given":"Lily C.","family":"Chow","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Cedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Wright","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Cedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Sola","sequence":"additional","affiliation":[{"name":"Division of Neonatal-Perinatal Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CSMC Oxygen Administration Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,2,1]]},"reference":[{"key":"2021121010082221000_R1","doi-asserted-by":"crossref","unstructured":"Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental fibroplasia. Pediatrics.1980;65:1096\u20131100","DOI":"10.1542\/peds.65.6.1096"},{"key":"2021121010082221000_R2","unstructured":"Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology.1991;98:1628\u20131640"},{"key":"2021121010082221000_R3","doi-asserted-by":"crossref","unstructured":"Bedrossian RH, Carmichael P, Ritter A. Retinopathy of prematurity (retrolental fibroplasia) and oxygen: part I. Clinical study: part II. Further observations on the disease. Am J Ophthalmol.1954;37:78\u201386","DOI":"10.1016\/0002-9394(54)92034-6"},{"key":"2021121010082221000_R4","unstructured":"Gaynon MW, Stevenson DK, Sunshine P, Fleisher BE, Landers MB. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol.1997;17:434\u2013438"},{"key":"2021121010082221000_R5","doi-asserted-by":"crossref","unstructured":"Kinsey VE, Arnold HJ, Kalina RE, et al. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics.1977;60:655\u2013668","DOI":"10.1542\/peds.60.5.655"},{"key":"2021121010082221000_R6","doi-asserted-by":"crossref","unstructured":"Phelps DL. Reduced severity of oxygen-induced retinopathy in kittens recovered in 28% oxygen. Pediatr Res.1988;24:106\u2013109","DOI":"10.1203\/00006450-198807000-00024"},{"key":"2021121010082221000_R7","doi-asserted-by":"crossref","unstructured":"Stuart MJ, Phelps DL, Setty BN. Changes in oxygen tension and effects on cyclooxygenase metabolites: III. Decrease of retinal prostacyclin in kittens exposed to hyperoxia. Pediatrics.1988;82:367\u2013372","DOI":"10.1542\/peds.82.3.367"},{"key":"2021121010082221000_R8","doi-asserted-by":"crossref","unstructured":"Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol.1996;114:1219\u20131228","DOI":"10.1001\/archopht.1996.01100140419009"},{"key":"2021121010082221000_R9","doi-asserted-by":"crossref","unstructured":"Robbins SG, Rajaratnam VS, Penn JS. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina. Growth Factors.1998;16:1\u20139","DOI":"10.3109\/08977199809017487"},{"key":"2021121010082221000_R10","doi-asserted-by":"crossref","unstructured":"Saito Y, Omoto T, Cho Y, Hatsukawa Y, Fujimura M, Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol.1993;231:151\u2013156","DOI":"10.1007\/BF00920938"},{"key":"2021121010082221000_R11","unstructured":"Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci.1995;36:2063\u20132070"},{"key":"2021121010082221000_R12","unstructured":"Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics.1991;87:953\u2013954"},{"key":"2021121010082221000_R13","doi-asserted-by":"crossref","unstructured":"Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989\u20131997. Pediatrics.1999;104(3). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/3\/e26","DOI":"10.1542\/peds.104.3.e26"},{"key":"2021121010082221000_R14","doi-asserted-by":"crossref","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol.1984;102:1130\u20131134","DOI":"10.1001\/archopht.1984.01040030908011"},{"key":"2021121010082221000_R15","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics.1997;100:273","DOI":"10.1542\/peds.100.2.273"},{"key":"2021121010082221000_R16","unstructured":"Screening examination of premature infants for retinopathy of prematurity. A joint statement of the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Ophthalmology.1997;104:888\u2013889"},{"key":"2021121010082221000_R17","unstructured":"Wischniewski E, Erler T, Avenarius S. Multicenter trial of neonatal pulse oximeter sensor usage: a difference between manufacturers. Anesth Analg.2002;94:S110"},{"key":"2021121010082221000_R18","doi-asserted-by":"crossref","unstructured":"Wilkinson AR, Phibbs RH, Gregory GA. Continuous measurement of oxygen saturation in sick newborn infants. J Pediatr.1978;93:1016\u20131019","DOI":"10.1016\/S0022-3476(78)81242-6"},{"key":"2021121010082221000_R19","unstructured":"Boyle KM, Baker VL, Cassaday CJ. Neonatal pulmonary disorders. In: Barnhart SL, Czervinske MP, eds. Perinatal and Pediatric Respiratory Care. Philadelphia, PA: WB Saunders; 1995:445\u2013479"},{"key":"2021121010082221000_R20","unstructured":"Liberman R, Holmes M, Taschuk R, Snelling L. Accuracy of pulse oximeters during neonatal motion. Respir Care.1999;44:1499"},{"key":"2021121010082221000_R21","unstructured":"Poets CF, Urschitz MS, Bohnhorst B, Peter CS. Pulse oximetry in the neonatal intensive care unit (NICU): detection of hyperoxemia and false alarm rates. Anesth Analg.2002;94:S37\u2013S40"},{"key":"2021121010082221000_R22","doi-asserted-by":"crossref","unstructured":"Goldstein MR, Barnum PT, Vogt J, Gangitano ES, Stephenson CG, Liberman RL. Conventional pulse oximetry can give spurious data in a neonatal population at risk for retinopathy of prematurity (ROP) [abstract]. Pediatr Res.1998;43:216A","DOI":"10.1203\/00006450-199804001-01281"},{"key":"2021121010082221000_R23","doi-asserted-by":"crossref","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: three-month outcome. Arch Ophthalmol.1990;108:195\u2013204","DOI":"10.1001\/archopht.1990.01070040047029"},{"key":"2021121010082221000_R24","doi-asserted-by":"crossref","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Arch Ophthalmol.1990;108:1408\u20131416","DOI":"10.1001\/archopht.1990.01070120056029"},{"key":"2021121010082221000_R25","doi-asserted-by":"crossref","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 5 1\/2 years after randomization. Arch Ophthalmol.1996;114:417\u2013424","DOI":"10.1001\/archopht.1996.01100130413008"},{"key":"2021121010082221000_R26","doi-asserted-by":"crossref","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Ophthalmological outcomes at 10 years. Arch Ophthalmol.2001;119:1110\u20131118","DOI":"10.1001\/archopht.119.8.1110"},{"key":"2021121010082221000_R27","doi-asserted-by":"crossref","unstructured":"McNamara JA, Tasman W, Brown GC, Federman JL. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology.1991;98:576\u2013580","DOI":"10.1016\/S0161-6420(91)32247-4"},{"key":"2021121010082221000_R28","doi-asserted-by":"crossref","unstructured":"Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology.1993;100:238\u2013244","DOI":"10.1016\/S0161-6420(93)31664-7"},{"key":"2021121010082221000_R29","doi-asserted-by":"crossref","unstructured":"Laser ROP Study Group. Laser therapy for retinopathy of prematurity. Arch Ophthalmol.1994;112:154\u2013156","DOI":"10.1001\/archopht.1994.01090140028007"},{"key":"2021121010082221000_R30","doi-asserted-by":"crossref","unstructured":"Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology.2002;109:936\u2013941","DOI":"10.1016\/S0161-6420(01)01015-6"},{"key":"2021121010082221000_R31","doi-asserted-by":"crossref","unstructured":"The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I. Primary outcomes. Pediatrics.2000;105:295\u2013310","DOI":"10.1542\/peds.105.2.295"},{"key":"2021121010082221000_R32","doi-asserted-by":"crossref","unstructured":"Hay WW Jr, Bell EF. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics.2000;105:424\u2013425","DOI":"10.1542\/peds.105.2.424"},{"key":"2021121010082221000_R33","doi-asserted-by":"crossref","unstructured":"Tin W, Milligan DWA, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed.2001;84:F106\u2013F110","DOI":"10.1136\/fn.84.2.F106"},{"key":"2021121010082221000_R34","unstructured":"Gramlicht T. Oxygen therapy. In: Barnhart SL, Czervinske MP, eds. Perinatal and Pediatric Respiratory Care. Philadelphia, PA: WB Saunders; 1995:156\u2013179"},{"key":"2021121010082221000_R35","unstructured":"Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: Psychological Corporation; 1993"},{"key":"2021121010082221000_R36","doi-asserted-by":"crossref","unstructured":"Sobel DB, Philip AG. Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics.1992;90:529\u2013533","DOI":"10.1542\/peds.90.4.529"},{"key":"2021121010082221000_R37","doi-asserted-by":"crossref","unstructured":"Cuculich PS, DeLozier KA, Mellen BG, Shenai JP. Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth-weight neonates. Biol Neonate2001;79:9\u201314","DOI":"10.1159\/000047059"},{"key":"2021121010082221000_R38","unstructured":"Sanchez V, del Moral T, Claure N, Vanbuskirk S, Flynn J, Bancalari E. Are postnatal steroids a risk factor for the development of retinopathy of prematurity in extremely low birth weight infants (ELBW)? [abstract]. Pediatr Res.2002;51:366A"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/2\/339\/1008036\/pe0203000339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/2\/339\/1008036\/pe0203000339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:45:18Z","timestamp":1682747118000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/2\/339\/66736\/Can-Changes-in-Clinical-Practice-Decrease-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2003,2,1]]},"published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.2.339","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}